Literature DB >> 8130185

Binding of an HIV Rev peptide to Rev responsive element RNA induces formation of purine-purine base pairs.

J L Battiste1, R Tan, A D Frankel, J R Williamson.   

Abstract

The Rev responsive element (RRE) is an RNA secondary structural element within the env gene of HIV and is the binding site for the viral Rev protein. Formation of the Rev-RRE complex is involved in regulation of splicing and transport of mRNA from the nucleus. To understand the structural basis for the specific recognition of RRE by Rev, we have studied a model system for this interaction using NMR. We have obtained a specific 1:1 complex between an RNA derived from stem IIB of RRE, which contains the highest affinity Rev binding site, and a modified Rev34-50 peptide, which binds the RRE as an alpha-helix [Tan, R., et al. (1993) Cell 73, 1031-1040]. Binding of the peptide was accompanied by a conformational change in the RNA, which resulted in the formation of additional base pairs not present in the free RNA. Two of these induced base pairs are purine-purine pairs within the internal loop of RRE, which had been previously proposed on the basis of biochemical experiments [Bartel, D.P., et al. (1991) Cell 67, 529-536]. The formation of non-Watson-Crick base pairs, interactions in the major groove, and protein-induced conformational changes may prove to be common characteristics of RNA recognition of proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8130185     DOI: 10.1021/bi00176a001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Comparative analysis of RNA/protein dynamics for the arginine-rich-binding motif and zinc-finger-binding motif proteins encoded by HIV-1.

Authors:  Hui Wang; Xiaojing Ma; Yu-Shan Yeh; Yongjin Zhu; Matthew D Daugherty; Alan D Frankel; Karin Musier-Forsyth; Paul F Barbara
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

2.  Evolvability of the mode of peptide binding by an RNA.

Authors:  Tetsuya Iwazaki; Xianglan Li; Kazuo Harada
Journal:  RNA       Date:  2005-07-25       Impact factor: 4.942

3.  Single-nucleotide changes in the HIV Rev-response element mediate resistance to compounds that inhibit Rev function.

Authors:  Deidra Shuck-Lee; Hua Chang; Emily A Sloan; Marie-Louise Hammarskjold; David Rekosh
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

4.  A DEAD-Box Helicase Mediates an RNA Structural Transition in the HIV-1 Rev Response Element.

Authors:  John A Hammond; Rajan Lamichhane; David P Millar; James R Williamson
Journal:  J Mol Biol       Date:  2017-01-31       Impact factor: 5.469

5.  Use of ultra stable UNCG tetraloop hairpins to fold RNA structures: thermodynamic and spectroscopic applications.

Authors:  M Molinaro; I Tinoco
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

6.  In vitro genetic analysis of the RNA binding site of vigilin, a multi-KH-domain protein.

Authors:  H Kanamori; R E Dodson; D J Shapiro
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Anti-peptide aptamers recognize amino acid sequence and bind a protein epitope.

Authors:  W Xu; A D Ellington
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  An RNA enhancer in a phage transcriptional antitermination complex functions as a structural switch.

Authors:  L Su; J T Radek; L A Labeots; K Hallenga; P Hermanto; H Chen; S Nakagawa; M Zhao; S Kates; M A Weiss
Journal:  Genes Dev       Date:  1997-09-01       Impact factor: 11.361

9.  Secondary structure of the 3' untranslated region of flaviviruses: similarities and differences.

Authors:  V Proutski; E A Gould; E C Holmes
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

Review 10.  A structurally plastic ribonucleoprotein complex mediates post-transcriptional gene regulation in HIV-1.

Authors:  Jason D Fernandes; David S Booth; Alan D Frankel
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-03-01       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.